HomeALZN • NASDAQ
add
Alzamend Neuro Inc
Previous close
$1.14
Day range
$1.10 - $1.18
Year range
$1.06 - $15.06
Market cap
6.14M USD
Avg Volume
164.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.36M | -53.20% |
Net income | -1.36M | 53.15% |
Net profit margin | — | — |
Earnings per share | -0.40 | 90.91% |
EBITDA | -1.35M | 53.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.09M | 1,945.73% |
Total assets | 5.01M | 409.12% |
Total liabilities | 1.25M | -65.77% |
Total equity | 3.75M | — |
Shares outstanding | 5.43M | — |
Price to book | 1.58 | — |
Return on assets | -101.69% | — |
Return on capital | -267.27% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -1.36M | 53.15% |
Cash from operations | -3.40M | -124.66% |
Cash from investing | 0.00 | — |
Cash from financing | 6.30M | 34,727.36% |
Net change in cash | 2.90M | 293.88% |
Free cash flow | -2.84M | -569.37% |
About
Founded
2016
Headquarters
Website
Employees
6
